Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

   |      |      |  

Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

Global Active Pharmaceutical Ingredients Market is accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.                         
               
Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.   
        
Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.

Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.

Business Modes Covered:
• Merchant Active Pharmaceutical Ingredients (API)
• Captive Active Pharmaceutical Ingredients (API)

Customer Bases Covered:
• Branded
• Generic

Type of Synthesis Covered:
• Biotech
• Synthetic

Applications Covered:
• Cardiology
• Neurology
• Oncology
• Ophthalmology
• Orthopedics
• Pulmonology

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary    
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Application Analysis  
 3.7 Emerging Markets   
 3.8 Futuristic Market Scenario  
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Active Pharmaceutical Ingredients Market, By Business Mode
 5.1 Introduction   
 5.2 Merchant Active Pharmaceutical Ingredients (API)
 5.3 Captive Active Pharmaceutical Ingredients (API)
      
6 Global Active Pharmaceutical Ingredients Market, By Customer Base

 6.1 Introduction   
 6.2 Branded    
 6.3 Generic    
      
7 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
 7.1 Introduction   
 7.2 Biotech    
 7.3 Synthetic    
      
8 Global Active Pharmaceutical Ingredients Market, By Application
 8.1 Introduction   
 8.2 Cardiology   
 8.3 Neurology   
 8.4 Oncology    
 8.5 Ophthalmology   
 8.6 Orthopedics   
 8.7 Pulmonology   
      
9 Global Active Pharmaceutical Ingredients Market, By Geography
 9.1 Introduction   
 9.2 North America   
  9.2.1 US   
  9.2.2 Canada   
  9.2.3 Mexico   
 9.3 Europe    
  9.3.1 Germany   
  9.3.2 UK   
  9.3.3 Italy   
  9.3.4 France   
  9.3.5 Spain   
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan   
  9.4.2 China   
  9.4.3 India   
  9.4.4 Australia   
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil   
  9.5.3 Chile   
  9.5.4 Rest of South America 
 9.6 Middle East & Africa  
  9.6.1 Saudi Arabia  
  9.6.2 UAE   
  9.6.3 Qatar   
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa 
      
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
 10.2 Acquisitions & Mergers  
 10.3 New Product Launch  
 10.4 Expansions   
 10.5 Other Key Strategies  
      
11 Company Profiling    
 11.1 Teva Active Pharmaceutical Industries Limited
 11.2 Ranbaxy Laboratories  
 11.3 Pfizer, Inc   
 11.4 Novartis    
 11.5 Mylan N.V   
 11.6 Lupin    
 11.7 Dr. Reddy's Lab   
 11.8 Boehringer Ingelheim GmbH  
 11.9 Aurobindo pharma   
 11.10 Albemarle Corporation  
 11.11 Ceva Animal Health, Inc.  
 11.12 Virbac    
 11.13 Sun Pharmaceutical Industries Ltd. 
 11.14 Merck Animal Health (U.S.)  
 11.15 Elanco Animal Health (U.S.)  
 11.16 Zoetis (U.S.)            
 11.17 Merial Inc. (Sanofi) (France)       
 11.18 Bioniche Animal Health (Canada)       
 11.19 Bayer Healthcare (Germany)       
 11.20 ELI Lilly and Company   
 11.21 Glaxosmithkline PLC   
 11.22 Abbvie Inc.   
 11.23 Sanofi     
 11.24 Bristol-Myers Squibb

Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

List of Tables     
1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2016-2026) (US $MN)
2 Global Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
3 Global Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
4 Global Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
5 Global Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
6 Global Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
7 Global Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
8 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
9 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
10 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
11 Global Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
12 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
13 Global Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
14 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
15 Global Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
16 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
17 Global Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)
18 North America Active Pharmaceutical Ingredients Market Outlook, By Country (2016-2026) (US $MN)
19 North America Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
20 North America Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
21 North America Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
22 North America Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
23 North America Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
24 North America Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
25 North America Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
26 North America Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
27 North America Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
28 North America Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
29 North America Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
30 North America Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
31 North America Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
32 North America Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
33 North America Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
34 North America Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)
35 Europe Active Pharmaceutical Ingredients Market Outlook, By Country (2016-2026) (US $MN)
36 Europe Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
37 Europe Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
38 Europe Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
39 Europe Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
40 Europe Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
41 Europe Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
42 Europe Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
43 Europe Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
44 Europe Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
45 Europe Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
46 Europe Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
47 Europe Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
48 Europe Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
49 Europe Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
50 Europe Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
51 Europe Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)
52 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Country (2016-2026) (US $MN)
53 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
54 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
55 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
56 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
57 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
58 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
59 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
60 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
61 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
62 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
63 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
64 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
65 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
66 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
67 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
68 Asia Pacific Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)
69 South America Active Pharmaceutical Ingredients Market Outlook, By Country (2016-2026) (US $MN)
70 South America Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
71 South America Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
72 South America Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
73 South America Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
74 South America Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
75 South America Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
76 South America Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
77 South America Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
78 South America Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
79 South America Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
80 South America Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
81 South America Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
82 South America Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
83 South America Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
84 South America Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
85 South America Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)
86 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Country (2016-2026) (US $MN)
87 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Business Mode (2016-2026) (US $MN)
88 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Merchant Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
89 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Captive Active Pharmaceutical Ingredients (API) (2016-2026) (US $MN)
90 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Customer Base (2016-2026) (US $MN)
91 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Branded (2016-2026) (US $MN)
92 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Generic (2016-2026) (US $MN)
93 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)
94 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Biotech (2016-2026) (US $MN)
95 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Synthetic (2016-2026) (US $MN)
96 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)
97 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Cardiology (2016-2026) (US $MN)
98 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Neurology (2016-2026) (US $MN)
99 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)
100 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Ophthalmology (2016-2026) (US $MN)
101 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Orthopedics (2016-2026) (US $MN)
102 Middle East & Africa Active Pharmaceutical Ingredients Market Outlook, By Pulmonology (2016-2026) (US $MN)

.